Monitoring of MxA mRNA Expression as a Marker of Rresponse to Interferon ß Therapy in Patients with Multiple Sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Interferon beta-1a (Primary) ; Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 08 Dec 2016 This trial was completed in Czech Republic (end date: 2015-01-19), according to European Clinical Trials Database.
- 17 Nov 2016 New trial record